DARE BIOSCIENCE INC. - COMMON STOCK
0.4853
17-May-24 15:59:50
15 minutes delayed
Stocks
+0.0505
+11.61%
Today's range
0.4299 - 0.4899
ISIN
N/A
Source
NASDAQ
-
Daré Bioscience Reports Third Quarter 2022 Financial Results and Provides a Company Update
10 Nov 2022 05:45:00 By Nasdaq GlobeNewswire
-
Daré Bioscience to Present at the Stifel 2022 Healthcare Conference
08 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
03 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
01 Nov 2022 08:00:00 By Nasdaq GlobeNewswire
-
Daré Bioscience Announces Positive Efficacy Results from the DARE-HRT1 Phase 1 / 2 Study
17 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Daré Bioscience to Participate in Two Upcoming Conferences
15 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
Daré Bioscience to Participate in H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 08:00:03 By Nasdaq GlobeNewswire
-
29 Aug 2022 08:00:00 By Nasdaq GlobeNewswire
-
24 Aug 2022 08:00:02 By Nasdaq GlobeNewswire
-
Daré Bioscience Reports Second Quarter 2022 Financial Results and Provides a Company Update
09 Aug 2022 08:00:03 By Nasdaq GlobeNewswire
-
02 Aug 2022 08:00:03 By Nasdaq GlobeNewswire
-
Daré Bioscience to Participate in Maxim Group Women’s Health Panel
07 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
Daré Bioscience Announces Partial Adjournment of Annual Meeting of Stockholders to July 14, 2022
24 Jun 2022 08:00:00 By Nasdaq GlobeNewswire
-
Daré Bioscience to Participate in the 2022 BIO International Convention
06 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Daré Bioscience to Participate in H.C. Wainwright Global Investment Conference
16 May 2022 08:00:01 By Nasdaq GlobeNewswire
-
Daré Bioscience Reports First Quarter 2022 Financial Results and Provides a Company Update
12 May 2022 06:00:00 By Nasdaq GlobeNewswire
-
Daré Bioscience Announces NIH Grant Award
11 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
05 May 2022 08:00:03 By Nasdaq GlobeNewswire